Partner With Us NRI

Trident Lifeline Ltd

Company details

6M Return 0.00%
1Y Return 32.96%
Mkt Cap.(Cr) 165.36
Volume 6,000
Div Yield 0.00%
OI Chg %
Volume 6,000

Open Free Demat Account Online with ICICIDIRECT



Operating Profit

Profit after Tax


Reserves and Surplus



Operating Profit

Profit after Tax






Equity Capital: 4.78 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 41.01 -16,297.57
LAST 3M 16,935.72 -4,368.10
LAST 6M 40,997.71 72,693.54
LAST 12M 176,172.92 -109,962.90


Stock PE (TTM)


Promoter Holding


Book Value







  • Trident Lifeline Limited was originally incorporated as Private Limited Company under the name "Trident Lifeline Private Limited" on January 09, 2014. Subsequently, Company converted into a Public Limited pursuant to Shareholders` Resolution on June 02, 2022 and name of Company was changed to "Trident Lifeline Limited" on June 10, 2022. The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market. It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. It operate in India as well as African, Latin American and East Indian Countries. Presently, it has presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venezuela. Presently, Company operates with one contract manufacturer, who maintained relationship with the regular supplier, having FDA and WHO approved plant to supply pharma formulations. These units manufacture tablets, capsules, dry powder, syrup under their own brands. Pharma business operations are supported by various contract manufacturers having facilities which are approved by FDA/WHO and other relevant authorities. The Company typically work on contract manufacturing basis or at times purchase order basis, depending upon customer`s requirement, with manufacturer of pharma products. The Company deal in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. The product portfolio comprises of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflammatory drug (NSAIDS). The Company had Certified its Quality Management System Under the Certificate ISO 9001: 2015 in FY 2021. Besides, product portfolio consists of 832 products, which operated under different brand names across the globe as on May 31, 2022. As on May 31, 2022, the Company has 267 products registered in total 8 countries, of which total 565 products are under process of registration in 11 countries.

No Data Found

AGM Date (Month) : Jul
Face Value Equity Shares : 10
Market Lot Equity Shares : 1200
BSE Code : 543616
NSE Code :
Book Closure Date (Month) :
BSE Group : M

ICICIdirect Trident Lifeline Ltd FAQ

You can buy Trident Lifeline Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Trident Lifeline Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jan 25, 2023 04:01 PM the closing price of Trident Lifeline Ltd was ₹ 143.80.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jan 25, 2023 04:01 PM, the market cap of Trident Lifeline Ltd stood at ₹ 165.36.
The latest PE ratio of Trident Lifeline Ltd as of Jan 25, 2023 04:01 PM is 73.37
The latest PB ratio of Trident Lifeline Ltd as of Jan 25, 2023 04:01 PM is 0.24
The 52-week high of Trident Lifeline Ltd is ₹ 179.95 while the 52-week low is ₹ 102.75

Download Our App

market app
market app